Open AccessThis article is
- freely available
Delineating an Epigenetic Continuum for Initiation, Transformation and Progression to Breast Cancer
Department of Otolaryngology/Head and Neck Surgery, Henry Ford Hospital, 1 Ford Place, 1D, Detroit, MI 48202, USA
Department of Pathology, Henry Ford Hospital, Detroit, 1 Ford Place, 1D, Detroit, MI 48202, USA
* Author to whom correspondence should be addressed.
Received: 13 January 2011; in revised form: 10 March 2011 / Accepted: 22 March 2011 / Published: 29 March 2011
Abstract: Aberrant methylation of promoter CpG islands is a hallmark of human cancers and is an early event in carcinogenesis. We examined whether promoter hypermethylation contributes to the pathogenesis of benign breast lesions along a progression continuum to invasive breast cancer. The exploratory study cohort comprised 17 breast cancer patients with multiple benign and/or in situ lesions concurrently present with invasive carcinoma within a tumor biopsy. DNA from tumor tissue, normal breast epithelium when present, benign lesions (fibroadenoma, hyperplasia, papilloma, sclerosing adenosis, apocrine metaplasia, atypical lobular hyperplasia or atypical ductal hyperplasia), and in situ lesions of lobular carcinoma and ductal carcinoma were interrogated for promoter methylation status in 22 tumor suppressor genes using the multiplex ligation-dependent probe amplification assay (MS-MLPA). Methylation specific PCR was performed to confirm hypermethylation detected by MS-MLPA. Promoter methylation was detected in 11/22 tumor suppressor genes in 16/17 cases. Hypermethylation of RASSF1 was most frequent, present in 14/17 cases, followed by APC in 12/17, and GSTP1 in 9/17 cases with establishment of an epigenetic monocloncal progression continuum to invasive breast cancer. Hypermethylated promoter regions in normal breast epithelium, benign, and premalignant lesions within the same tumor biopsy implicate RASSF1, APC, GSTP1, TIMP3, CDKN2B, CDKN2A, ESR1, CDH13, RARB, CASP8, and TP73 as early events. DNA hypermethylation underlies the pathogenesis of step-wise transformation along a monoclonal continuum from normal to preneoplasia to invasive breast cancer.
Keywords: benign; premalignant; transformation; DNA methylation; progression; continuum
Citations to this Article
Cite This Article
MDPI and ACS Style
Chen, K.M.; Stephen, J.K.; Raju, U.; Worsham, M.J. Delineating an Epigenetic Continuum for Initiation, Transformation and Progression to Breast Cancer. Cancers 2011, 3, 1580-1592.
Chen KM, Stephen JK, Raju U, Worsham MJ. Delineating an Epigenetic Continuum for Initiation, Transformation and Progression to Breast Cancer. Cancers. 2011; 3(2):1580-1592.
Chen, Kang Mei; Stephen, Josena K.; Raju, Usha; Worsham, Maria J. 2011. "Delineating an Epigenetic Continuum for Initiation, Transformation and Progression to Breast Cancer." Cancers 3, no. 2: 1580-1592.